# Biomedical Textiles Market

> Biomedical Textiles Market Research Report Information By Fiber Type (Non-Biodegradable, Biodegradable), Fabric Type (Woven, Non-Woven), Product Type (Non-Implantable, Implantable), Applications (Dentistry, General Surgery & Treatment), Region – Forecast Till 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.42%
- **2024:** $ 18.72 Billion
- **2025:** $ 19.92 Billion
- **2035:** $ 37.12 Billion
- **Key Players:** Medtronic (US), Johnson & Johnson (US), Baxter International (US), Smith & Nephew (GB), Stryker Corporation (US), 3M Company (US), Cardinal Health (US), Hollister Incorporated (US), Acelity (US)

**Report ID:** MRFR/CnM/4621-HCR · **Pages:** 100 · **Author:** Priya Nagrale · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/biomedical-textiles-market-6079

---

## Market Summary

## **Biomedical Textiles Market Overview**

Biomedical Textiles Market Size was valued at USD 17.63 billion in 2023. The Biomedical Textiles Market industry is projected to grow from USD 18.72 Billion in 2024 to USD 30.30 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.4% during the forecast period (2024 - 2032). Biomedical textiles are fabrics that have been specifically created for use in biological conditions. The biocompatibility of these fabrics with biological cells, tissue, and fluids determines their performance. They are part of the medical textiles branch of the technical textiles department.

Non-toxic, non-carcinogenic, non-allergic biomedical textiles should be sterilized, chemically inert, biocompatible, high strength, flexible, and have outstanding durability. End-use applications for biomedical textiles include ophthalmology, neurology, cardiology, dentistry, orthopedics, general surgery and therapy, and others. Healthcare and hygiene items, non-implantable products, implantable products, and extracorporeal devices are all examples of biomedical textiles in use. Surgical garments, surgical drapes, beddings, sanitary napkins, baby diapers, adult incontinence products, and other healthcare and hygiene goods are used to protect healthcare staff and patients from contamination by blood and other infectious fluids.

Non-implantable goods are used to provide protection against infection, absorption and exudation of blood and excess fluids, and healing applications through external application to the body with or without skin contact. Over the projected period, the global biomedical textiles market is expected to be driven by expanding healthcare budgets, rising health awareness, and rising healthcare expenditure.

## Biomedical Textiles Market Key Players

Some of the prominent players in the global biomedical textiles market are [Secant Group, LLC](https://secant.com/biomedical-textiles-advance-development-of-orthopedic-implants/) (U.S.), [Confluent Medical Technologies](https://confluentmedical.com/capabilities/biomedical-textiles/) (U.S.), SWICOFIL AG (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Meister & Cie AG (Switzerland), Cardinal Health. (U.S.), Smith & Nephew (UK), Medline Industries, Inc (India), Integra LifeSciences Corporation. (U.S.), PAUL HARTMANN AG (Germany), BSN medical. (Germany), B. Braun Melsungen AG (Germany), 3M (U.S.), Elkem Silicones (Norway), and ATEX TECHNOLOGIES (U.S.).

**Global Biomedical Textiles Market Share in 2017, by Product Type**

Source: MRFR Analysis

### **Market Segmentation**

The global biomedical textiles market is segmented by fiber type, fabric type, product type, application, and region.

On the basis of the fiber type, the global biomedical textiles market is segmented into the non-biodegradable fiber and biodegradable fiber.  Non-biodegradable fiber is sub-segmented into polypropylene, polyethylene, polyester, polyamide, polyurethane, [polytetrafluoroethylene](../../../reports/polytetrafluoroethylene-market-1740), and others. Biodegradable fiber is sub-segmented into cotton, viscose rayon, collagen, chitin, and others.

On the basis of the fabric type, the global biomedical textiles market is segmented into woven, non-woven, knitted & braided fabrics, hollow fabric, and others.

On the basis of the product type, the global biomedical textiles market is segmented into healthcare & hygiene products, non-implantable products, implantable products, and extracorporeal devices. Healthcare & hygiene products are sub-segmented into surgical clothing, surgical drapes, beddings, sanitary napkins, baby diapers, adult incontinence products, and others. Non-implantable products are sub-segmented into bandages, wound care dressings, plasters, gauze, and others. Implantable products are sub-segmented into soft tissue implants (hernia repair, ligament implant), hard tissue implants (orthopedic implant, dental implant), cardiovascular implants (vascular graft, heart valve), surgical sutures, and others. Extracorporeal devices are sub-segmented into artificial kidney, liver, and lungs.

Based on applications, the global biomedical textiles market is segmented into ophthalmology, neurology, cardiology, dentistry, orthopedics, general surgery & treatment, and others.

### **Regional Analysis**

The global biomedical textiles market is segmented into five regions namely Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa. 

Asia Pacific was a lucrative market for biomedical textiles in 2017 and is expected to witness a considerable demand during the forecast period. A large population base in Asia Pacific drives the strong need for healthcare facilities to combat cases of the aging population, rising cases of chronic & lifestyle diseases, accident cases; this is likely to boost demand of biomedical textiles in healthcare industry during the forecast period.

Additionally, growing foreign investments in healthcare sector due to relaxed investments norms as well as various government initiatives such as high budget allocation for healthcare sector is likely to impact the healthcare industry positively and thus are expected to surge the demand for biomedical textiles over the forecast period.

North America and Europe market are relatively mature and are expected to witness steady demand for biomedical textiles owing to the limited growth scope during the forecast period.

The Middle East & Africa is expected to witness rising demand for biomedical textiles mostly from GCC countries owing to their growing healthcare expanding projects to strengthen the industry during the forecast period.

Latin America is expected to witness a moderate growth over the forecast period. Brazil healthcare industry is expected to drive the largest demand for biomedical textiles, followed by a demand from Mexico, Chile, Peru, and Columbia country.

### Biomedical Textiles Market Industry Developments

- **Q2 2024: Confluent Medical Technologies Announces Expansion of Biomedical Textile Manufacturing Facility in Costa Rica** Confluent Medical Technologies opened a new, expanded biomedical textile manufacturing facility in Costa Rica to increase production capacity for implantable medical textiles used in cardiovascular and orthopedic devices.
- **Q1 2024: Secant Group Launches Regenerez™ Bioabsorbable Textile Platform for Regenerative Medicine** Secant Group introduced Regenerez™, a new bioabsorbable textile platform designed for use in regenerative medicine applications, expanding its biomedical textile product portfolio.
- **Q2 2024: DSM Biomedical and Terumo Aortic Announce Strategic Partnership for Textile-Based Vascular Grafts** DSM Biomedical entered a strategic partnership with Terumo Aortic to co-develop advanced textile-based vascular grafts, leveraging DSM’s biomedical textile technology for next-generation cardiovascular implants.
- **Q3 2024: Poly-Med, Inc. Receives FDA 510(k) Clearance for Biofelt™ Absorbable Textile Scaffold** Poly-Med, Inc. received FDA 510(k) clearance for its Biofelt™ absorbable textile scaffold, enabling commercialization of the product for soft tissue repair and regenerative medicine applications.
- **Q2 2024: Freudenberg Medical Expands Biomedical Textile Production with New Facility in Massachusetts** Freudenberg Medical opened a new manufacturing facility in Massachusetts dedicated to the production of biomedical textiles for implantable medical devices, aiming to meet growing demand in the U.S. market.
- **Q1 2025: Medtronic Acquires Textile-Based Hernia Mesh Startup Synovis for $150 Million** Medtronic completed the acquisition of Synovis, a startup specializing in textile-based hernia mesh implants, to strengthen its surgical solutions portfolio.
- **Q2 2025: B. Braun Launches New Line of Antimicrobial Surgical Sutures Using Advanced Textile Technology** B. Braun introduced a new line of antimicrobial surgical sutures made with advanced biomedical textile technology, targeting infection reduction in surgical procedures.
- **Q1 2024: Stryker Announces $100 Million Investment in Biomedical Textile R&D Center** Stryker announced a $100 million investment to establish a new research and development center focused on biomedical textiles for orthopedic and soft tissue repair devices.
- **Q3 2024: Cardinal Health Signs Multi-Year Supply Agreement for Implantable Textile Mesh with Advanced Medical Solutions** Cardinal Health entered a multi-year supply agreement with Advanced Medical Solutions to source implantable textile mesh for use in surgical and wound care products.
- **Q2 2025: Integra LifeSciences Receives CE Mark for New Textile-Based Dura Substitute** Integra LifeSciences received CE Mark approval for its new textile-based dura substitute, allowing commercialization in the European Union for neurosurgical applications.
- **Q1 2025: Lydall Invests $50 Million in Expansion of Biomedical Textile Operations in North Carolina** Lydall announced a $50 million investment to expand its biomedical textile manufacturing operations in North Carolina, increasing capacity for medical implant and wound care products.
- **Q2 2024: Avient Corporation Launches New Biocompatible Textile Fiber for Implantable Medical Devices** Avient Corporation launched a new biocompatible textile fiber designed for use in implantable medical devices, expanding its offerings in the biomedical textiles sector.

### **Intended Audience**

## Market Drivers

### Emergence of Regenerative Medicine

The Biomedical Textiles Market is witnessing a transformative impact from the emergence of [regenerative medicine](https://www.marketresearchfuture.com/reports/regenerative-medicine-market-2220). This field focuses on repairing or replacing damaged tissues and organs, which necessitates the development of specialized textiles that can support cellular growth and tissue regeneration. The integration of biomedical textiles in regenerative applications, such as scaffolds for tissue engineering, is gaining traction. As research progresses, the market is expected to evolve, with projections indicating a potential increase in demand for regenerative textile products. This evolution reflects the broader trend of personalized medicine and the need for innovative solutions in healthcare.

### Rising Demand for Healthcare Services

The Biomedical Textiles Market is significantly influenced by the rising demand for healthcare services across various regions. As populations age and chronic diseases become more prevalent, the need for effective medical textiles is escalating. This trend is reflected in the increasing investments in healthcare infrastructure, which is expected to reach trillions in the coming years. Consequently, the demand for biomedical textiles, including surgical gowns, drapes, and implantable devices, is anticipated to rise. The market is likely to witness a robust growth trajectory, fueled by the necessity for high-quality, reliable medical textiles that meet stringent regulatory standards.

### Growing Awareness of Infection Control

The Biomedical Textiles Market is benefiting from a heightened awareness of infection control measures in healthcare settings. The increasing incidence of hospital-acquired infections has prompted healthcare providers to adopt advanced textile solutions that offer antimicrobial properties. This shift is leading to a growing preference for textiles that can effectively reduce the risk of infections during surgical procedures and patient care. The market for antimicrobial biomedical textiles is projected to expand, with estimates suggesting a growth rate of around 7% annually. This trend underscores the critical role of biomedical textiles in enhancing patient safety and improving healthcare outcomes.

### Sustainability Initiatives in Textile Production

The Biomedical Textiles Market is increasingly influenced by sustainability initiatives aimed at reducing the environmental impact of textile production. Manufacturers are adopting eco-friendly materials and processes, which not only appeal to environmentally conscious consumers but also comply with regulatory requirements. The shift towards sustainable practices is expected to drive innovation in the development of biodegradable and recyclable biomedical textiles. As a result, the market is likely to see a rise in the adoption of sustainable textiles, with estimates suggesting that eco-friendly products could account for a significant share of the market by 2030. This trend highlights the importance of aligning healthcare solutions with environmental stewardship.

### Technological Advancements in Biomedical Textiles

The Biomedical Textiles Market is experiencing a surge in technological advancements that enhance the functionality and performance of textile products. Innovations such as 3D printing and nanotechnology are being integrated into textile manufacturing processes, allowing for the creation of customized and complex structures. These advancements not only improve the mechanical properties of textiles but also enable the incorporation of bioactive agents that promote healing. As a result, the market is projected to grow at a compound annual growth rate of approximately 8% over the next five years, driven by the increasing demand for advanced wound care solutions and surgical implants.

## Future Outlook

The Biomedical Textiles Market is projected to grow at a 6.42% CAGR from 2025 to 2035, driven by technological advancements, increasing healthcare demands, and rising awareness of biocompatible materials.

**New opportunities:**

- Development of smart textiles for real-time health monitoring.
- 
- Expansion of biodegradable textile solutions for sustainable healthcare.
- Investment in R&D for advanced wound care products using nanofibers.

By 2035, the Biomedical Textiles Market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Fiber Type: Non-biodegradable Fiber (Largest) vs. Biodegradable Fiber (Fastest-Growing)

In the Biomedical Textiles Market, Non-biodegradable fibers currently command the largest share among fiber types used in medical textiles. As a result of their durability and resistance to degradation, these fibers are preferred for various applications such as sutures, implants, and prosthetics. Conversely, Biodegradable fibers represent a growing segment as they align with the increasing demand for sustainable and eco-friendly medical solutions. Their ability to break down naturally in the body makes them particularly attractive for temporary implants and wound dressings. The growth trends in the Fiber Type segment highlight the shift towards sustainability and biocompatibility in biomedical applications. The increasing awareness of environmental impacts and the push for sustainable materials in healthcare are driving the demand for Biodegradable fibers. At the same time, advancements in fiber technology and regulatory support are enhancing the adoption of Non-biodegradable fibers for critical applications, ensuring their continued relevance in the market.

Fiber Type: Non-biodegradable Fiber (Dominant) vs. Biodegradable Fiber (Emerging)

Non-biodegradable fibers dominate the Biomedical Textiles Market primarily due to their durability, strength, and performance characteristics, making them essential in high-stakes applications such as surgical sutures, vascular grafts, and orthopedic implants. These fibers provide long-lasting solutions in situations where material performance is critical. On the other hand, biodegradable fibers are emerging rapidly as the biomedical industry shifts towards compliance with sustainability initiatives. These fibers, often derived from natural polymers, contribute to reduced waste and environmental impact, positioning them as suitable materials for temporary medical devices and wound care applications. As research and technology in this sector advance, the growing preference for eco-friendly solutions may further enhance the performance and acceptance of Biodegradable fibers.

### By Fabric Type: Woven (Largest) vs. Non-woven (Fastest-Growing)

The Biomedical Textiles Market showcases various fabric types, with woven fabrics commanding the largest share. Their structural integrity and reliability make them ideal for a range of medical applications, including surgical gowns and drapes. Conversely, non-woven fabrics are rapidly gaining traction, primarily due to their versatility and cost-effectiveness, catering to disposable items such as masks and wound dressings.

Woven (Dominant) vs. Non-woven (Emerging)

Woven fabrics hold a dominant position in the Biomedical Textiles Market due to their superior strength and durability, making them suitable for long-term use in various healthcare settings. These fabrics are often used in surgical textiles and implantable devices where performance and safety are paramount. In contrast, [non-woven fabrics](https://www.marketresearchfuture.com/reports/nonwoven-fabrics-market-7459) are emerging as a significant player, driven by their affordable production and suitability for single-use products, which are in high demand during public health emergencies. The ease of mass production and adaptability of non-woven materials present them as a popular choice for hospitals, particularly in high-volume applications that require sterility and convenience.

### By Product Type: Healthcare & hygiene products (Largest) vs. Implantable products (Fastest-Growing)

In the Biomedical Textiles Market, the distribution of market share among the product types reveals that healthcare and hygiene products dominate significantly due to their widespread applications in surgical and post-operative care. This segment's robustness is driven by increasing demand for infection control and prevention in medical environments. On the other hand, implantable products also hold a substantial position in the market, characterized by the increasing prevalence of chronic diseases necessitating surgical interventions, which boosts their demand across healthcare facilities.

Healthcare & hygiene products (Dominant) vs. Implantable products (Emerging)

Healthcare and hygiene products represent the dominant segment within the Biomedical Textiles Market, well-regarded for their extensive use in various healthcare applications including gowns, drapes, and wound dressings. These products are essential for maintaining hygiene standards in medical settings and are supported by innovations in materials that enhance functionality and safety. Conversely, implantable products are viewed as an emerging segment, rapidly gaining traction owing to advancements in material technologies and an increase in surgical procedures. These products, including sutures and meshes, are designed to integrate with the human body, emphasizing biocompatibility and durability. The growth in this segment is fueled by rising aging populations and advancements in medical procedures.

### By Application: Orthopedics (Largest) vs. Ophthalmology (Fastest-Growing)

The Biomedical Textiles Market showcases a diverse application landscape, with Orthopedics emerging as the largest segment. This sector has garnered substantial market share due to the high prevalence of musculoskeletal disorders and sports injuries, leading to an increased demand for advanced orthopedic textiles. Other significant segments include Cardiology and General Surgery, which also manifest a steady demand. However, Ophthalmology is quickly gaining traction, positioning itself as the fastest-growing segment due to heightened awareness about eye-related health issues and advancements in textile technology for eye surgeries. Growth trends in the Biomedical Textiles Market are primarily driven by technological innovations and a rise in disposable income across various regions. The increasing incidence of chronic diseases necessitates superior biomedical textile solutions for effective treatment. Moreover, the pace of research and development activities is accelerating, yielding new products that cater to diverse medical applications. As healthcare continues to evolve, the focus on high-quality, biodegradable, and patient-friendly textiles signals a promising outlook for various applications within this market.

Orthopedics (Dominant) vs. Ophthalmology (Emerging)

Orthopedics is currently the dominant segment in the Biomedical Textiles Market, characterized by a range of products such as surgical meshes, wound dressings, and implants that are engineered to support the musculoskeletal system. This segment benefits from a robust pipeline of innovative materials specifically designed to facilitate faster recovery and enhance biomechanical properties. In contrast, Ophthalmology represents an emerging segment that is rapidly gaining market share facilitated by innovative approaches in textiles used for eye surgeries, such as sutures and eye patches. The demand for minimally invasive surgical procedures in Ophthalmology is driving the development of specialized textiles, thus creating a favorable environment for market growth. As both segments evolve, they will continue to shape the landscape of biomedical textiles with their unique contributions and specialized applications.

## Regional Market Share Analysis

### North America : Market Leader in Innovation

North America is the largest market for biomedical textiles, holding approximately 45% of the global share. The region benefits from advanced healthcare infrastructure, significant R&D investments, and a growing aging population that drives demand for innovative medical solutions. Regulatory support from agencies like the FDA further catalyzes market growth by ensuring safety and efficacy in biomedical products. The United States is the primary contributor, with key players such as Medtronic, Johnson & Johnson, and Baxter International leading the charge. The competitive landscape is characterized by continuous innovation and strategic partnerships among major companies. This dynamic environment fosters advancements in materials and technologies, ensuring that North America remains at the forefront of the biomedical textiles market.

### Europe : Emerging Market with Potential

Europe is the second-largest market for biomedical textiles, accounting for around 30% of the global share. The region is witnessing a surge in demand driven by an increasing prevalence of chronic diseases and a focus on advanced wound care solutions. Regulatory frameworks, such as the EU Medical Device Regulation, are enhancing product safety and efficacy, thereby boosting market confidence and growth. Leading countries include Germany, France, and the UK, where companies like Smith & Nephew and 3M Company are prominent. The competitive landscape is marked by innovation and collaboration among manufacturers, healthcare providers, and research institutions. This synergy is crucial for developing new products that meet the evolving needs of the healthcare sector.

### Asia-Pacific : Rapid Growth and Expansion

Asia-Pacific is rapidly emerging as a significant player in the biomedical textiles market, holding about 20% of the global share. The region's growth is fueled by rising healthcare expenditures, increasing awareness of advanced medical technologies, and a growing population. Countries like China and India are investing heavily in healthcare infrastructure, which is expected to drive demand for biomedical textiles in the coming years. China is leading the charge, with a burgeoning market for medical devices and textiles. The competitive landscape features both local and international players, including Stryker Corporation and Cardinal Health. The presence of a large manufacturing base and favorable government policies further enhance the region's attractiveness for biomedical textile production and innovation.

### Middle East and Africa : Untapped Market Potential

The Middle East and Africa region is gradually emerging in the biomedical textiles market, currently holding about 5% of the global share. The growth is driven by increasing healthcare investments, a rising prevalence of lifestyle diseases, and a focus on improving healthcare infrastructure. Governments are implementing policies to enhance healthcare access, which is expected to catalyze market growth in the coming years. Countries like South Africa and the UAE are at the forefront, with a growing number of healthcare facilities and investments in medical technologies. The competitive landscape is still developing, with opportunities for both local and international players to establish a foothold. The presence of key players is limited but growing, indicating a promising future for biomedical textiles in this region.

## Competitive Benchmarking

The Biomedical Textiles Market is currently characterized by a dynamic competitive landscape, driven by innovation, technological advancements, and strategic partnerships. Key players such as Medtronic (US), Johnson & Johnson (US), and Baxter International (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Medtronic (US) focuses on integrating advanced materials into their product lines, aiming to improve patient outcomes through innovative textile solutions. Meanwhile, Johnson & Johnson (US) emphasizes sustainability in its operations, aligning its product development with eco-friendly practices. Baxter International (US) is actively pursuing mergers and acquisitions to expand its portfolio, thereby enhancing its competitive edge in the biomedical textiles sector.The business tactics employed by these companies reflect a concerted effort to optimize supply chains and localize manufacturing. The market structure appears moderately fragmented, with a mix of established players and emerging companies vying for market share. This fragmentation allows for diverse product offerings, yet the collective influence of major players like Stryker Corporation (US) and 3M Company (US) is significant, as they set industry standards and drive innovation.
In August Stryker Corporation (US) announced a strategic partnership with a leading textile manufacturer to develop next-generation surgical meshes. This collaboration is poised to enhance Stryker's product offerings, particularly in minimally invasive surgeries, thereby positioning the company as a leader in innovative biomedical textiles. The partnership underscores the importance of collaboration in driving technological advancements within the sector.
In September 3M Company (US) launched a new line of antimicrobial [wound dressings](https://www.marketresearchfuture.com/reports/wound-dressing-market-21740) that utilize advanced textile technology. This product introduction not only reflects 3M's commitment to innovation but also addresses the growing demand for effective infection control solutions in healthcare settings. The strategic importance of this launch lies in its potential to capture market share in a highly competitive segment, reinforcing 3M's position as a key player in the biomedical textiles market.
In October [Johnson & Johnson](https://www.jnj.com/en-in) (US) unveiled a new initiative aimed at enhancing the sustainability of its biomedical textiles through the use of recycled materials. This initiative is indicative of a broader trend towards sustainability in the industry, as companies increasingly recognize the importance of environmentally responsible practices. By prioritizing sustainability, Johnson & Johnson is likely to appeal to a growing segment of environmentally conscious consumers and healthcare providers.
As of October the competitive trends within the Biomedical Textiles Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming more prevalent, as companies seek to leverage each other's strengths to enhance product offerings and operational efficiencies. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability, suggesting a transformative shift in how companies position themselves in the market.

## Recent News & Developments

- **Q2 2024: Confluent Medical Technologies Announces Expansion of Biomedical Textile Manufacturing Facility in Costa Rica** Confluent Medical Technologies opened a new, expanded biomedical textile manufacturing facility in Costa Rica to increase production capacity for implantable medical textiles used in cardiovascular and orthopedic devices.
- **Q1 2024: Secant Group Launches Regenerez™ Bioabsorbable Textile Platform for Regenerative Medicine** Secant Group introduced Regenerez™, a new bioabsorbable textile platform designed for use in regenerative medicine applications, expanding its biomedical textile product portfolio.
- **Q2 2024: DSM Biomedical and Terumo Aortic Announce Strategic Partnership for Textile-Based Vascular Grafts** DSM Biomedical entered a strategic partnership with Terumo Aortic to co-develop advanced textile-based vascular grafts, leveraging DSM’s biomedical textile technology for next-generation cardiovascular implants.
- **Q3 2024: Poly-Med, Inc. Receives FDA 510(k) Clearance for Biofelt™ Absorbable Textile Scaffold** Poly-Med, Inc. received FDA 510(k) clearance for its Biofelt™ absorbable textile scaffold, enabling commercialization of the product for soft tissue repair and regenerative medicine applications.
- **Q2 2024: Freudenberg Medical Expands Biomedical Textile Production with New Facility in Massachusetts** Freudenberg Medical opened a new manufacturing facility in Massachusetts dedicated to the production of biomedical textiles for implantable medical devices, aiming to meet growing demand in the U.S. market.
- **Q1 2025: Medtronic Acquires Textile-Based Hernia Mesh Startup Synovis for $150 Million** Medtronic completed the acquisition of Synovis, a startup specializing in textile-based hernia mesh implants, to strengthen its surgical solutions portfolio.
- **Q2 2025: B. Braun Launches New Line of Antimicrobial Surgical Sutures Using Advanced Textile Technology** B. Braun introduced a new line of antimicrobial surgical sutures made with advanced biomedical textile technology, targeting infection reduction in surgical procedures.
- **Q1 2024: Stryker Announces $100 Million Investment in Biomedical Textile R&D Center** Stryker announced a $100 million investment to establish a new research and development center focused on biomedical textiles for orthopedic and soft tissue repair devices.
- **Q3 2024: Cardinal Health Signs Multi-Year Supply Agreement for Implantable Textile Mesh with Advanced Medical Solutions** Cardinal Health entered a multi-year supply agreement with Advanced Medical Solutions to source implantable textile mesh for use in surgical and wound care products.
- **Q2 2025: Integra LifeSciences Receives CE Mark for New Textile-Based Dura Substitute** Integra LifeSciences received CE Mark approval for its new textile-based dura substitute, allowing commercialization in the European Union for neurosurgical applications.
- **Q1 2025: Lydall Invests $50 Million in Expansion of Biomedical Textile Operations in North Carolina** Lydall announced a $50 million investment to expand its biomedical textile manufacturing operations in North Carolina, increasing capacity for medical implant and wound care products.
- **Q2 2024: Avient Corporation Launches New Biocompatible Textile Fiber for Implantable Medical Devices** Avient Corporation launched a new biocompatible textile fiber designed for use in implantable medical devices, expanding its offerings in the biomedical textiles sector.

### **Intended Audience**

- Biomedical textiles manufacturers
- Traders and distributors of biomedical textiles
- Research and development institutes
- Potential investors
- Raw material suppliers
- Nationalized laboratory

## Report Scope

| MARKET SIZE 2024 | 18.72(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 19.92(USD Billion) |
| MARKET SIZE 2035 | 37.12(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.42% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Medtronic (US), Johnson & Johnson (US), Baxter International (US), Smith & Nephew (GB), Stryker Corporation (US), 3M Company (US), Cardinal Health (US), Hollister Incorporated (US), Acelity (US) |
| Segments Covered | Fiber Type |
| Key Market Opportunities | Advancements in smart textiles enhance patient monitoring and treatment in the Biomedical Textiles Market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the Biomedical Textiles Market. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the current valuation of the Biomedical Textiles Market in 2025?**
A: The Biomedical Textiles Market is valued at approximately 18.72 USD Billion in 2024.

**Q: What is the projected market size for the Biomedical Textiles Market by 2035?**
A: The market is projected to reach around 37.12 USD Billion by 2035.

**Q: What is the expected CAGR for the Biomedical Textiles Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Biomedical Textiles Market during the forecast period 2025 - 2035 is 6.42%.

**Q: Which companies are considered key players in the Biomedical Textiles Market?**
A: Key players in the market include Medtronic, Johnson & Johnson, Baxter International, and Stryker Corporation.

**Q: What are the main segments of the Biomedical Textiles Market based on fiber type?**
A: The main segments based on fiber type include Non-biodegradable fiber, valued at 22.45 USD Billion, and Biodegradable fiber, valued at 14.67 USD Billion.

**Q: How do the different fabric types perform in the Biomedical Textiles Market?**
A: In 2025, Non-woven fabrics are projected to generate 11.22 USD Billion, while Woven fabrics are expected to reach 7.48 USD Billion.

**Q: What product types are included in the Biomedical Textiles Market?**
A: Product types include Implantable products, projected to reach 12.0 USD Billion, and Healthcare & hygiene products, expected to generate 9.0 USD Billion.

**Q: Which applications are driving growth in the Biomedical Textiles Market?**
A: Applications such as Cardiology and Orthopedics are expected to drive growth, with projected values of 7.25 USD Billion and 6.19 USD Billion, respectively.

**Q: What is the significance of biodegradable fibers in the Biomedical Textiles Market?**
A: Biodegradable fibers are projected to reach a market value of 14.67 USD Billion, indicating a growing trend towards sustainable materials.

**Q: How does the market for extracorporeal devices compare to other product types?**
A: The market for extracorporeal devices is expected to reach 9.12 USD Billion, highlighting its importance alongside other product types.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/biomedical-textiles-market-6079*